by Talking Medicines | Apr 14, 2021
Data insights firm Talking Medicines, specialist in ‘social intelligence’ for the pharmaceutical industry, has appointed Donna Lawson to the position of Head of Data Quality. A particularly good fit for the role, Donna brings with her over two decades’ experience...
by Talking Medicines | Mar 3, 2021
Pharma Business International spoke with Jo Halliday, CEO of Talking Medicines, the world’s first social intelligence company designed specifically for the pharmaceutical industry. The full article can be found here on page 10-11 Tell us about Talking Medicines?...
by Talking Medicines | Feb 4, 2021
Talking Medicines is the world’s first social intelligence company designed specifically for the pharmaceutical industry: PatientMetrx By structuring and translating the patient’s voice on social media into actionable intelligence, it focuses on assisting...
by Talking Medicines | Jan 22, 2021
In December Talking Medicines carried out two ‘pulse’ surveys of the UK public to gauge opinion towards COVID-19 vaccines and found that over the month, attitude had softened, with more people intending to take the vaccine once it becomes available to them. The...
by Talking Medicines | Jan 20, 2021
We are so pleased to welcome four talented individuals to our team. Through their knowledge and experience, we look forward to accelerating our AI driven data insights product aligned to the needs of our commercial marketing pharmaceutical customers. Stewart McKee...
by Talking Medicines | Jan 5, 2021
COO Elizabeth Fairley was recently interviewed by publisher Drug Discovery World on whether the pharmaceutical industry is ready to listen directly to patients? Elizabeth commented that “There has been a growing realisation that pharmaceutical companies must...
